Tenon Medical (NASDAQ:TNON – Get Free Report) and Anteris Technologies Global (NASDAQ:AVR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends.
Analyst Ratings
This is a summary of current recommendations and price targets for Tenon Medical and Anteris Technologies Global, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tenon Medical | 1 | 0 | 2 | 0 | 2.33 |
| Anteris Technologies Global | 1 | 0 | 1 | 0 | 2.00 |
Tenon Medical presently has a consensus target price of $3.00, suggesting a potential upside of 306.06%. Anteris Technologies Global has a consensus target price of $15.00, suggesting a potential upside of 162.70%. Given Tenon Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Tenon Medical is more favorable than Anteris Technologies Global.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tenon Medical | $3.28 million | 2.50 | -$13.67 million | ($1.77) | -0.42 |
| Anteris Technologies Global | $2.70 million | 87.13 | -$76.29 million | ($1.81) | -3.15 |
Tenon Medical has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Tenon Medical and Anteris Technologies Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tenon Medical | -396.26% | -409.04% | -114.60% |
| Anteris Technologies Global | -3,944.93% | -252.71% | -169.61% |
Institutional & Insider Ownership
22.7% of Tenon Medical shares are held by institutional investors. 0.3% of Tenon Medical shares are held by insiders. Comparatively, 4.5% of Anteris Technologies Global shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Volatility and Risk
Tenon Medical has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Anteris Technologies Global has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500.
Summary
Tenon Medical beats Anteris Technologies Global on 10 of the 14 factors compared between the two stocks.
About Tenon Medical
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
